Novel pena mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan
|
|
- Helena Atkins
- 5 years ago
- Views:
Transcription
1 J Antimicrob Chemother 2016; 71: doi: /jac/dkw161 Advance Access publication 13 May 2016 Novel pena mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan Kensaku Seike 1, Mitsuru Yasuda 1, Kyoko Hatazaki 1, Kosuke Mizutani 1, Kazuya Yuhara 2, Yasuhisa Ito 3, Yoshinori Fujimoto 4, Shin Ito 5, Tomohiro Tsuchiya 1, Shigeaki Yokoi 1, Masahiro Nakano 1 and Takashi Deguchi 1 * 1 Department of Urology, Graduate School of Medicine, Gifu University, Gifu, Japan; 2 Department of Urology, Japanese Red Cross Takayama Hospital, Takayama, Japan; 3 Department of Urology, Ibi Kosei Hospital, Ibi, Japan; 4 Department of Urology, Ogaki Municipal Hospital, Ogaki, Japan; 5 iclinic, Sendai, Japan Introduction *Corresponding author. Tel: ; Fax: ; deguchit@gifu-u.ac.jp K. Seike and M. Yasuda contributed equally to this article. Received 25 January 2016; returned 2 March 2016; revised 6 April 2016; accepted 7 April 2016 Objectives: We examined four clinical strains of Neisseria gonorrhoeae (GU030113, GU110095, GU and GU110362) isolated between 2000 and 2014 in Japan, exhibiting ceftriaxone MICs of 0.5 mg/l, for mutations of the genes associated with penicillin resistance. Methods: The pena, mtrr, porb1b (penb), pona and pilq genes of the strains were sequenced. PBP2s of the strains were aligned to the PBP2s associated with decreased susceptibility to oral cephalosporins, and PBP2s of previously reported strains with decreased susceptibility to ceftriaxone. Results: GU had PBP2 pattern X with an additional substitution of A502T. GU had PBP2 pattern XXVII. GU had PBP2 pattern XXXIV with an additional substitution of P552S. GU had PBP2 composed of pattern X (amino acid positions 1 291) and pattern V (amino acid positions ). GU030113, GU and GU had, G120K and A121D or A121N in PorB1b and L421P in PBP1. GU had A40D in the repressor of MtrR and L421P in PBP1. The strains did not have mutations of pilq1 and pilq2. Conclusions: Addition of A502T to PBP2 pattern X in GU and of P552S to PBP2 pattern XXXIV in GU would possibly contribute to decreased susceptibility to ceftriaxone. In GU and GU110362, it was suggested that, in addition to their altered PBP2s, the enhanced efflux pump, reduced permeability in the outer membrane, another altered target of b-lactams and/or other mechanisms not identified in the present study might contribute to decreased susceptibility. Surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae in Japan has shown that clinical isolates with decreased susceptibility to oral third-generation cephalosporins, including cefixime, have emerged and spread since the early 2000s. 1 Clinical isolates with cefixime MICs of 0.25 mg/l and 0.5 mg/l accounted for 40.8% and 10.7% of the isolates collected in Japan from 2012 to 2013, respectively. 2 However, most clinical isolates of N. gonorrhoeae with decreased susceptibility to cefixime still exhibit ceftriaxone MICs of 0.25 mg/l or less. 1 3 In 2009, a clinical strain (H041) of N. gonorrhoeae with a ceftriaxone MIC of 2 mg/l was isolated from the pharynx of a female sex worker in Japan, 4 while in 2010, another strain of F89 with ceftriaxone MICs of 1 2 mg/l was isolated in France and Spain. 5,6 Afurther five strains with ceftriaxone MICs of 0.5 mg/l have also been reported Chromosomally mediated penicillin resistance in N. gonorrhoeae is conferred by multifactorial genetic alterations, including those of the pena, mtrr, porb1b (penb), pona and pilq genes For decreased susceptibility to cefixime and ceftriaxone, alterations of PBP2 encoded by the pena gene, particularly mosaic structures of PBP2 composed of fragments analogous to PBP2s in commensal 3 11,13 17 Neisseria species, play a principal role. Our surveillance of antimicrobial susceptibility of N. gonorrhoeae in Japan since 2000 has identified five isolates with ceftriaxone MICs of 0.5 mg/l among 2126 isolates tested. The mechanism of resistance of one strain (GU140106) has been reported previously. 11 In the present study, we examined the four other strains for mutations in the genes associated with b-lactam resistance # The Author Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please journals.permissions@oup.com 2466
2 N. gonorrhoeae with decreased susceptibility to ceftriaxone JAC as well as their relatedness to other strains previously reported to have decreased susceptibility to ceftriaxone. Methods The four isolates with ceftriaxone MICs of 0.5 mg/l (GU030113, GU110095, GU and GU110362) were successfully recovered from storage at 2708C. MICs of penicillin G (Wako Pure Chemical Industries, Ltd, Osaka, Japan), cefixime (Astellas Pharma, Tokyo, Japan), ceftriaxone (Chugai Pharmaceutical Co., Ltd, Tokyo, Japan), tetracycline (Wako Pure Chemical Industries, Ltd), azithromycin (Sigma Aldrich Corporation, St Louis, MO, USA), spectinomycin (LKT Laboratories, Inc., St Paul, MN, USA) and levofloxacin (Daiichi Sankyo Company, Ltd, Tokyo, Japan) were determined again by the agar dilution method. 18 N. gonorrhoeae ATCC49226 was used as the quality control strain. The pena, mtrr, porb1b (penb), pona and pilq genes of the strains were sequenced as previously described. 3,13,14 The pena genes of GU030113, GU110095, GU and GU were deposited in GenBank under accession nos LC113985, LC114149, LC and LC113986, respectively. The PBP2s derived from the pena genes were aligned to PBP2 of penicillin-susceptible strain LM306 (GenBank accession no. M32091), PBP2 pattern V associated with penicillin resistance, 3 PBP2s (patterns V, X and XXXIV) associated with decreased susceptibility to cefixime, 3,15 PBP2s of two strains with ceftriaxone MICs of 1 2 mg/l (H041 and F89) and PBP2s of five strains with ceftriaxone MICs of 0.5 mg/l isolated in Japan in 2000 or 2001 (GP853), China in 2007, Austria in 2011, Australia in 2013 (A8806) and Japan in 2014 (GU140106) In the following text and Table 1, the amino acid positions in PBP2 are identified according to numbering of the NCBI reference sequence of N. gonorrhoeae PBP2 pattern V (GenBank accession no. WP_ ). Molecular epidemiological characterization of the strains was performed by means of MLST and N. gonorrhoeae multiantigen sequence typing (NG-MAST) as previously reported. 4,5 This study was approved by the Institutional Review Board of the Graduate School of Medicine, Gifu University, Gifu, Japan (reference no ). Results and discussion Table 1. Characteristics of the four clinical strains of N. gonorrhoeae with decreased susceptibility to ceftriaxone Characteristic GU030113, GU and GU were isolated from the urethra of men with gonococcal urethritis (Table 1). GU Strain GU GU GU GU Isolation of the strains year specimen source urethral swab urethral swab urethral swab pharyngeal swab Demographics of patients sex male male male male age (years) sexual partner casual woman female sex worker girlfriend female sex worker symptoms dysuria and urethral dysuria and urethral dysuria and urethral asymptomatic treatment 100 mg of cefcapene pivoxil three times/day for 7 days test-of-cure for N. gonorrhoeae not performed not performed not performed negative culture result of pharyngeal swab MIC (mg/l) of antimicrobial agents penicillin G cefixime ceftriaxone tetracycline azithromycin spectinomycin levofloxacin Analysis of the pena, mtrr, porb1b, pona and pilq genes PBP2 X+A502T XXVII XXXIV+P552S X (1-291)+V ( ) mtrr/mtrr A40D in the repressor of MtrR PorB1b G120K, A121D G120K, A121N G120K, A121N PBP1 L421P L421P L421P L421P PilQ type VII type VII type VII type VI Genotyping MLST NG-MAST
3 Seike et al. was isolated from the pharynx of an asymptomatic man. The three men with gonococcal urethritis were treated with ceftriaxone or cefcapene, but the test-of-cure for N. gonorrhoeae was not performed. The asymptomatic man with the pharyngeal infection was treated with a single dose of 1 g of ceftriaxone. Culture of the pharyngeal swab was negative for N. gonorrhoeae 17 days after treatment. The decreased susceptibility of all four isolates to ceftriaxone (MIC 0.5 mg/l) was confirmed on re-testing after retrieval from frozen storage. In addition, all four isolates were resistant to penicillin G, tetracycline and levofloxacin based on the breakpoints of ofloxacin (Table 1). 19 They showed decreased susceptibility to cefixime and ceftriaxone. The MICs of azithromycin ranged from 0.25 to 1 mg/l. In Japan, a single-dose regimen of extended-release azithromycin (2 g) is available to treat gonorrhoea. Our previous study on the microbiological efficacy of this regimen on gonococcal urethritis suggested that GU and GU with azithromycin MICs of 1 mg/l might be resistant to this regimen. 20 For spectinomycin, all of the strains were susceptible. Although all the strains had altered PBP2 (Table 1), their PBP2s did not match any of the previously reported strains with decreased susceptibility to ceftriaxone (Figure 1) GU had an additional substitution of A502T in PBP2 pattern X. In F89 with ceftriaxone MICs of 1 2 mg/l, A502P was found in its mosaic PBP2. 5 In the Chinese strain with a ceftriaxone MIC of 0.5 mg/l, A502V was found in its non-mosaic PBP2. 8 The substitutions at amino acid position 502 in PBP2s, including A502T, were reported to contribute to decreased susceptibility to ceftriaxone. 16 For GU030113, A502T could possibly contribute to decreased susceptibility to ceftriaxone, although transformation studies are needed to confirm its association with decreased susceptibility to ceftriaxone. GU had mosaic PBP2 pattern XXXIV with P552S. F89 had mosaic PBP2 pattern XXXIV with A502P and the Austrian strain with a ceftriaxone MIC of 0.5 mg/l had mosaic PBP2 pattern XXXIV with T535A. 5,9 Strains of N. gonorrhoeae harbouring mosaic PBP2s, including pattern XXXIV, commonly decrease their susceptibility to cefixime, but do not always decrease ceftriaxone susceptibility. 3,4,7,8,15 17 SM-1, SM-2 and SM-3 strains having PBP2 pattern XXXIV, which were collected in 2008 in San Francisco, USA, exhibited cefixime MICs of mg/l, but ceftriaxone MICs of mg/l. 15 A previous transformation study reported that the introduction of PBP2 pattern XXXIV with an additional substitution at amino acid position 502 or 552 increased ceftriaxone MICs in a ceftriaxonesusceptible strain. 17 Based on this finding, the decreased susceptibility to ceftriaxone of strain GU110332, which had PBP2 belonging to pattern XXXIV, might reflect an additional substitution at amino acid position 552. For GU and GU110362, it is uncertain whether their respective PBP2 pattern XXVII and novel PBP2 could contribute to their decreased susceptibility to ceftriaxone. GU030113, GU and GU had a single nucleotide deletion in the mtrr, G120K and A121D or A121N in PorB1b and L421P in PBP1 (Table 1). GU had A40D in the repressor of MtrR and L421P in PBP1. The A40D in the repressor of MtrR detected in GU was different from A39T or G45D reported to confer increased resistance to hydrophobic antimicrobials. 12 It is uncertain whether A40D could contribute to enhanced efflux pump activity in GU Other alterations detected in the Figure 1. Sequences of only the altered amino acids in PBP2 of N. gonorrhoeae strains GU030113, GU110095, GU and GU110362, which are aligned to the WT PBP2 of the pena gene of penicillin-susceptible strain LM306, PBP2 pattern V associated with penicillin resistance, PBP2 patterns X and XXXIV associated with decreased susceptibility to oral cephalosporins, PBP2s of H041 and F89 with high-level resistance to ceftriaxone and PBP2s of GP853, the Chinese strain isolated in 2007, A8806, the Austrian strainisolatedin2011andgu140106withdecreasedsusceptibilityto ceftriaxone. The amino acid positions in PBP2 were identified according to numbering of the NCBI reference sequence of N. gonorrhoeae PBP2 pattern V (GenBank accession no. WP_ ). 2468
4 N. gonorrhoeae with decreased susceptibility to ceftriaxone JAC mtrr, PorB1b and PBP1 were associated with penicillin resistance in N. gonorrhoeae. The strains had a PilQ amino acid ST of VI or VII, but did not have mutations of pilq1 (F595L) and pilq2 (E666K) associated with penicillin susceptibility. 14 GP853 with a ceftriaxone MIC of 0.5 mg/l did not have substitutions associated with decreased susceptibility to ceftriaxone such as those at amino acid position 311, 316, 474, 502 or 552 in its mosaic PBP2. 7 However, GP853 had penicillin resistance-associated genetic mutations in the mtrr, porb1b (penb) and/or pona genes, which were identical or analogous to those observed in our strains. In such strains as GU110095, GU and GP853, it was suggested that in addition to alterations of PBP2s, enhanced efflux pump activity and reduced permeability in the outer membrane, another altered target of b-lactams and/or other mechanisms not identified in this study might contribute to the decreased susceptibility to ceftriaxone. The strains were assigned to the following MLSTs: GU and GU as ST1901, GU as ST9751 and GU as ST7363 (Table 1). NG-MAST assigned all four strains to different types. H041, A8806 and GU140106, which had substitutions at amino acid positions 311, 316 and/or 484, had the MLST of ST ,10,11 One way such strains evolve into ceftriaxone-resistant ones might be by acquiring substitutions at amino acid position 311, 316 or 484. F89, the Austrian strain and GU harbouring PBP2 pattern XXXIV with an additional substitution had the MLST of ST ,9 Another way such strains evolve into ceftriaxoneresistant ones might be by acquiring additional substitutions in PBP2 pattern XXXIV. The prevalence of clinical isolates of N. gonorrhoeae exhibiting ceftriaxone MICs of 0.5 mg/l is still low. However, the emergence and spread of such isolates might be the prelude to the wider emergence of strains that are fully resistant to ceftriaxone, which would be a major public health crisis were it to happen. Acknowledgements We thank the patients of the Japanese Red Cross Takayama Hospital (Takayama, Japan), Ibi Kosei Hospital (Ibi, Japan), Ogaki Municipal Hospital (Ogaki, Japan) and iclinic (Sendai, Japan). Funding This work was supported in part by the Japan Society for the Promotion of Science (JSPS), Japan [Grant-in-Aid for Scientific Research (C) and (C) ]. Transparency declarations None to declare. Author contributions Study concept and design: K. S., M. Y. and T. D. Acquisition of data: K. S., M. Y., K. H., K. Y., Y. I., Y. F. and S. I. Analysis and interpretation of data: K.S.,M.Y.,K.H.,K.M.,T.T.,S.Y.andM.N.Draftingofthemanuscript: K. S., M. Y. and T. D. Critical revision of the manuscript for important intellectual content: K. M., T. T., S. Y. and M. N. Obtaining funding: M. Y. and T. D. Supervision: T. D. References 1 Ito M, Yasuda M, Yokoi S et al. Remarkable increase in central Japan in of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48: Hamasuna R, Yasuda M, Ishikawa K et al. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, J Infect Chemother 2005; 21: Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillinbinding protein 2 in Central Japan. Antimicrob Agents Chemother 2005; 49: Ohnishi M, Golparian D, Shimuta K et al. IsNeisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: Unemo M, Golparian D, Nicholas R et al. High-levelcefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel pena mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: Cámara J, Serra J, Ayats J et al. Molecular characterization of two highlevel ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012; 67: Tanaka M, Nakayama H, Huruya K et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents 2006; 27: Chen SC, Yin YP, Dai XQ et al. Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother 2014; 69: Unemo M, Golparian D, Stary A et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, Euro Surveill 2011; 16: pii¼ Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med 2014; 371: Deguchi T, Yasuda M, Hatazaki K et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg Infect Dis 2016; 22: Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 2008; 70: Lindberg R, Fredlund H, Nicholas R et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in pena, mtrr, porb1b, andpona. Antimicrob Agents Chemother 2007; 51: Whiley DM, Jacobsson S, Tapsall JW et al. Alterations of the pilq gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother 2010; 65: Pandori M, Barry PM, Wu A et al. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 2009; 53: Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7: Shimuta K, Unemo M, Nakayama S et al. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, 2469
5 Seike et al. Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother 2013; 57: Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, Yasuda M, Ito S, Kido A et al. A single 2 g oral dose of extended-release azithromycin for treatment of gonococcal urethritis. J Antimicrob Chemother 2014; 69:
* these authors contributed equally to the preparation of this report
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationMolecular mechanisms of antibiotic resistance in Neisseria gonorrhoeae
medicaldaily.com http://en.vircell.com/diseases ppcorn.com Molecular mechanisms of antibiotic resistance in Neisseria gonorrhoeae Robert Nicholas University of North Carolina at Chapel Hill cdc.gov Timeline
More informationEmergence, spread and characteristics of Neisseria
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden Daniel Golparian, Bengt Hellmark,
More informationTreatment resistant STIs relevant to MSM
Treatment resistant STIs relevant to MSM David A. Lewis FRCP (UK) PhD Centre for HIV and STIs National Institute for Communicable Diseases (NHLS) Johannesburg, South Africa Regional Director, IUSTI Africa
More informationCDC Grand Rounds: The Growing Threat of Multidrug-
Page 1 of 8 Morbidity and Mortality Weekly Report (MMWR) CDC Grand Rounds: The Growing Threat of Multidrug- Resistant Gonorrhea Weekly February 15, 2013 / 62(06);103-106 Although gonorrhea has afflicted
More informationDiversity of pena Alterations and Subtypes in Neisseria gonorrhoeae Strains from Sydney, Australia, That Are Less Susceptible to Ceftriaxone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2007, p. 3111 3116 Vol. 51, No. 9 0066-4804/07/$08.00 0 doi:10.1128/aac.00306-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Diversity
More informationReceived 10 March 2011/Returned for modification 19 April 2011/Accepted 2 May 2011
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2011, p. 3538 3545 Vol. 55, No. 7 0066-4804/11/$12.00 doi:10.1128/aac.00325-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Is Neisseria
More informationHigh-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel
AAC Accepts, published online ahead of print on 12 December 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.05760-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationAntimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011
Olsen et al. BMC Infectious Diseases 2013, 13:40 RESEARCH ARTICLE Open Access Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011 Birgitta Olsen
More informationBECAUSE OF NEISSERIA GONORrhoeae
PRELIMINARY COMMUNICATION Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada Vanessa G. Allen, MD, MPH Leo Mitterni Christine Seah, MLT Anuradha Rebbapragada, PhD
More informationNIH Public Access Author Manuscript Future Microbiol. Author manuscript; available in PMC 2013 October 01.
NIH Public Access Author Manuscript Published in final edited form as: Future Microbiol. 2012 December ; 7(12): 1401 1422. doi:10.2217/fmb.12.117. Emergence of multidrug-resistant, extensively drug-resistant
More informationTrends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae
International Journal of Antimicrobial Agents 31S (2008) S35 S39 Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae T. Matsumoto Department of Urology, School
More informationDetailed characterization of the first high-level ceftriaxone resistant strain.
AAC Accepts, published online ahead of print on 16 May 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.00325-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationEmergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes
Emergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes Cécile Bébéar French National Center for bacterial STIs Bordeaux University
More informationGonorrhea Antimicrobial Resistance in Alberta. Gonorrhea Antimicrobial Resistance Review
2011 Review in Alberta Alberta Gonorrhea AMR Surveillance Working Group November 2013 2011 Review Background Gonorrhea remains one of the oldest infections known to man. Infections can result in significant
More informationIn vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae
AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment
More informationAntimicrobial resistance and molecular epidemiology of Neisseria gonorrhoeae in New Zealand,
Antimicrobial resistance and molecular epidemiology of Neisseria gonorrhoeae in New Zealand, 2014-15 December 2015 PREPARED FOR: CLIENT REPORT No: PREPARED BY: Ministry of Health FW15061 Helen Heffernan,
More informationNucleic acid amplification testing for Neisseria gonorrhoeae where are we going?
Nucleic acid amplification testing for Neisseria gonorrhoeae where are we going? David Whiley QPID Laboratory, Queensland Children s Medical Research Institute, Children s Health Service District, and
More informationRapid communication.
Rapid communication Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and highlevel azithromycin resistance, England, February 2018 David W Eyre 1,2, Nicholas
More informationNeisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M.
UvA-DARE (Digital Academic Repository) Neisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M. Link to publication Citation for published version
More informationMultidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
Downloaded from orbit.dtu.dk on: Jun 07, 2018 Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017 Terkelsen, David;
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More informationAntimicrobial Resistance of Neisseria gonorrhoeae Isolated in Korea
Journal of Bacteriology and Virology 2012. Vol. 42, No. 1 p.9 16 http://dx.doi.org/10.4167/jbv.2012.42.1.9 Review Article Antimicrobial Resistance of Neisseria gonorrhoeae Isolated in Korea Hyukmin Lee
More informationAntimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in
Sethi et al. BMC Infectious Diseases 2013, 13:35 RESEARCH ARTICLE Open Access Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan
More informationUpdate on Treatment Options for Gonococcal Infections
Update on Treatment Options for Gonococcal Infections Jason W. Lancaster, 1,2, * Monica V. Mahoney, 3 Sana Mandal, 1 and Kenneth R. Lawrence, 4 1 School of Pharmacy, Northeastern University, Boston, Massachusetts;
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationMolecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use?
REVIEW C URRENT OPINION Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? Nicola Low a and Magnus Unemo b Purpose of review Molecular methods
More informationRésistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar
Résistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar French Na*onal Center for bacterial STIs Bordeaux University hospital, Bordeaux, France University of Bordeaux,
More informationMolecular characterization of Neisseria gonorrhoeae on non-cultured specimens from multiple anatomic sites
Ann Ist Super Sanità 2017 Vol. 53, No. 3: 213-217 DOI: 10.4415/ANN_17_03_06 Molecular characterization of Neisseria gonorrhoeae on non-cultured specimens from multiple anatomic sites Anna Carannante 1,
More informationAmsterdam, the Netherlands 9 Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the
JCM Accepted Manuscript Posted Online 22 February 2017 J. Clin. Microbiol. doi:10.1128/jcm.00100-17 Crown copyright 2017. The government of Australia, Canada, or the UK ("the Crown") owns the copyright
More informationSai Li 1, Xiao-Hong Su 1*, Wen-Jing Le 1, Fa-Xing Jiang 2, Bao-Xi Wang 1 and Peter A Rice 3
Li et al. BMC Infectious Diseases 2014, 14:622 RESEARCH ARTICLE Open Access Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted
More informationNeisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M.
UvA-DARE (Digital Academic Repository) Neisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M. Link to publication Citation for published version
More informationRecent trends in gonorrhoea and syphilis epidemiology in Sweden: 2007 to 2011
Rapid communications Recent trends in gonorrhoea and syphilis epidemiology in Sweden: 27 to 211 I Velicko (inga.velicko@smi.se) 1, M Unemo 2 1. Swedish Institute for Communicable Disease Control (Smittskyddsinstitutet),
More informationM u lt i d r u g - r e s i s ta n t N e i s s e r i a g o n o r r h o e a e w i t h
R e s e a rc h a r ti cl e s M u lt i d r u g - r e s i s ta n t N e i s s e r i a g o n o r r h o e a e w i t h r e d u c e d c e f o ta x i m e s u s c e p t i b i l i t y i s i n c r e a s i n g ly
More informationMeeting Report. 7 9 April 2010 Manila, Philippines
Meeting Report Consultation on the Strategic Response to the Threat of Untreatable Neisseria gonorrhoeae and Emergence of Cephalosporin Resistance in Neisseria gonorrhoeae 7 9 April 2010 Manila, Philippines
More information6. Gonococcal antimicrobial susceptibility
6. Gonococcal antimicrobial susceptibility Key points Gonococcal AMR continues to increase worldwide and could lead to a pandemic of extensively drug-resistant (XDR) N. gonorrhoeae with serious public
More informationInternationell utblick STI/HIV i världen
Internationell utblick STI/HIV i världen Magnus Unemo, PhD, Assoc. Professor, Director Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology Örebro University
More informationEndimiani et al. BMC Infectious Diseases 2014, 14:106
Endimiani et al. BMC Infectious Diseases 2014, 14:106 RESERCH RTICLE Open ccess Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998 2012): emergence of multidrug-resistant
More informationManagement of Gonorrhea in Adolescents and Adults in the United States
SUPPLEMENT ARTICLE Management of Gonorrhea in Adolescents and Adults in the United States Sarah Kidd 1 and Kimberly A. Workowski 1,2 1 Division of STD Prevention, Centers for Disease Control and Prevention,
More informationThe Emerging Threat of Cephalosporin (& Multidrug) Resistant Gonorrhea
The Emerging Threat of Cephalosporin (& Multidrug) Resistant Gonorrhea Robert D. Kirkcaldy, MD, MPH Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, TB and STD Prevention Centers
More informationThe Gonococcal Antimicrobial Surveillance Program (GASP): A snapshot from Southern Africa Dumisile Venessa Maseko
The Gonococcal Antimicrobial Surveillance Program (GASP): A snapshot from Southern Africa Dumisile Venessa Maseko Centre for HIV and STIs Na9onal Ins9tute for Communicable Diseases, Na9onal Health Laboratory
More informationNeisseria gonorrhoeae: The Ontario perspective. Michael Whelan and Dr. Vanessa Allen PHO Grand Rounds, May 5, 2015
Neisseria gonorrhoeae: The Ontario perspective Michael Whelan and Dr. Vanessa Allen PHO Grand Rounds, May 5, 2015 Objectives Participants will be able to: Describe preferred specimen collection for testing
More informationZoliflodacin (ETX0914) for Uncomplicated Gonorrhoea
Zoliflodacin (ETX0914) for Uncomplicated Gonorrhoea Global Antibiotic Research and Development Partnership, Pasteur Institute, 29 February, 2016 Entasis Therapeutics - Introduction Entasis Therapeutics
More informationNeisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel
AAC Accepts, published online ahead of print on 26 November 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.01775-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Neisseria
More informationRecent Trends in Neisseria gonorrhoeae Infection
Sexually Transmitted Diseases Recent Trends in Neisseria gonorrhoeae Infection JMAJ 45(12): 499 505, 2002 Shoichi ONODERA Professor, Department of Urology, The Jikei University School of Medicine Abstract:
More informationIncreasing Incidence of High-Level Tetracycline- Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import
Original Article Yonsei Med J 2016 Mar;57(2):350-357 pissn: 0513-5796 eissn: 1976-2437 Increasing Incidence of High-Level Tetracycline- Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign
More informationA Multiplex Real-Time PCR with High Resolution Melting Analysis for the. Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae
JCM Accepted Manuscript Posted Online 25 May 2016 J. Clin. Microbiol. doi:10.1128/jcm.03354-15 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 A Multiplex Real-Time PCR with
More informationNeisseria gonorrhoeae 2009
Magnus Unemo Date: 2010-05-12 Page 1 of 7 Neisseria gonorrhoeae 2009 Annual report regarding serological characterisation and antibiotic susceptibility of Swedish Neisseria gonorrhoeae strains In 2009,
More informationSTD UPDATE Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018
Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018 MISSION Improve health outcomes in communities disproportionately impacted by HIV and STDs Collect, study and publish data Diagnose and
More informationORIGINAL ARTICLES. Antibiotic-resistant gonococci past, present and future. The pre-antibiotic era. David A Lewis
Antibiotic-resistant gonococci past, present and future David A Lewis 1146 Gonorrhoea remains one of the commonest STIs from a global perspective and, left untreated or treated inadequately, may result
More informationCharacterisation of bla TEM genes and types of β- lactamase plasmids in Neisseria gonorrhoeae the prevalent and conserved bla
Characterisation of bla TEM genes and types of β- lactamase plasmids in Neisseria gonorrhoeae the prevalent and conserved bla TEM-135 has not recently evolved and existed in the Toronto plasmid from the
More informationSingle-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea
Original Article Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea Stephanie N. Taylor, M.D., Jeanne Marrazzo, M.D., M.P.H., Byron E. Batteiger, M.D., Edward W. Hook, III, M.D.,
More informationNeisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M.
UvA-DARE (Digital Academic Repository) Neisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M. Link to publication Citation for published version
More informationGenotypes and antimicrobial resistant phenotypes of Neisseria gonorrhoeae in
Author manuscript, published in "Sexually Transmitted Infections 86, 6 (2010) 449" DOI : 10.1136/sti.2010.044321 Genotypes and antimicrobial resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004-2009)
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationMuhammad et al. BMC Infectious Diseases 2014, 14:454
Muhammad et al. BMC Infectious Diseases 2014, 14:454 RESEARCH ARTICLE Open Access Characterisation of bla TEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae the prevalent and conserved
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationREPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA
i Report on the enhanced surveillance of antimicrobial-resistant gonorrhea REPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA RESULTS FROM THE 2014 PILOT i TO PROMOTE AND PROTECT
More informationNational Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae
National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2011 Streptococcus and STI Unit Bacteriology and Enteric Diseases Program National Microbiology Laboratory
More informationGepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation Stephanie N Taylor, Louisiana State University David H Morris, Desert AIDS Project
More informationin 2004 the Russian gonococcal antimicrobial susceptibility
Surveillance and outbreak reports The Russian gonococcal antimicrobial susceptibility programme (RU-GASP) national resistance prevalence in 2007 and 2008, and trends during 2005-2008 A Kubanova 1, N Frigo
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationNeisseria gonorrhoeae 2007
Magnus Unemo Date: 2008-03-14 Page 1 of 6 Neisseria gonorrhoeae 2007 Annual report regarding serological characterisation and antibiotic susceptibility of Swedish Neisseria gonorrhoeae strains In 2007,
More informationNational Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2012
1 National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2012 National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2012
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided
More informationANTIBIOTIC-RESISTANT GONORRHEA: THE CURRENT THREAT AND FUTURE PUBLIC HEALTH IMPLICATIONS. Vanessa Gatskie. B.A., American University, 2010
ANTIBIOTIC-RESISTANT GONORRHEA: THE CURRENT THREAT AND FUTURE PUBLIC HEALTH IMPLICATIONS by Vanessa Gatskie B.A., American University, 2010 Submitted to the Graduate Faculty of Behavioral and Community
More informationSexually Transmitted Disease Surveillance 1998 Supplement
Sexually Transmitted Disease Surveillance 1998 Supplement Division of STD Prevention November 1999 Gonococcal Isolate Surveillance Project (GISP) Annual Report - 1998 DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationNeisseria gonorrhoeae azithromycin susceptibility in the United States, the Gonococcal Isolate Surveillance Project:
AAC Accepts, published online ahead of print on 1 December 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.04337-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Neisseria
More informationGonorrhea Shrinking treatment options
CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Gonorrhea Shrinking treatment options 31 March 2011 Gonorrhea is a relatively common infection among men who have sex with men, but it
More informationMAJOR ARTICLE. It recently has been shown that as many as 42% of endocervical swab samples obtained from female sex
MAJOR ARTICLE Treatment Failure with the Use of Ciprofloxacin for Gonorrhea Correlates with the Prevalence of Fluoroquinolone-Resistant Neisseria gonorrhoeae Strains in Bangladesh Motiur Rahman, 1 Ashraful
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - December 2011
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - ember 211 Kirstine Eastick PhD FRCPath (Director) SBSTIRL, Microbiology Edinburgh
More informationNational Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2014
1 National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2012 National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2014
More informationRises in STI Rates: Who, What, Why, and What Public Health Can Do
Number of Cases 5/24/2018 Rises in STI Rates: Who, What, Why, and What Public Health Can Do Katherine Hsu, MD, MPH, FAAP* Medical Director, Div. of STD Prev., Mass. Dept. of Pub. Health Associate Professor
More informationThis genus includes two species pathogenic for humans:
THE GENUS NEISSERIA Neisseriae are gramnegative cocci arranged in pairs, so they are diplococci. This genus includes two species pathogenic for humans: N. gonorrhoeae (s.c. gonococci) N. meningitidis (s.c.
More informationANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA
ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA Mafunise M 1, Le Roux MC 1, de Villiers BE 1, Ditsele RMM 1,2 1 Department of Microbiological
More informationExtensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia. Main conclusions and options for response
RAPID RISK ASSESSMENT Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia 7 May 2018 Main conclusions and options for response The first three cases of infection
More informationEmergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH
Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.
More informationORIGINAL ARTICLE. 120 J Formos Med Assoc 2010 Vol 109 No 2
ORIGINAL ARTICLE High Prevalence of Mutations in Quinolone-resistance-determining Regions and mtrr Loci in Polyclonal Neisseria gonorrhoeae Isolates at a Tertiary Hospital in Southern Taiwan Po-Lin Chen,
More informationReceived 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005
Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,
More informationSustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study
Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study Helen Fifer, Michelle Cole, Gwenda Hughes, Simon Padfield, Christa Smolarchuk, Neil
More informationIncidence and Treatment Outcomes of Pharyngeal. Infections in Men Who Have Sex with Men: A 13-Year Retrospective Cohort Study
MAJOR ARTICLE Incidence and Treatment Outcomes of Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis Infections in Men Who Have Sex with Men: A 13-Year Retrospective Cohort Study Kaede V. Ota,
More informationNeisseria gonorrhoeae 2008
Magnus Unemo Date: 2009-03-21 Page 1 of 7 Neisseria gonorrhoeae 2008 Annual report regarding serological characterisation and antibiotic susceptibility of Swedish Neisseria gonorrhoeae strains In 2008,
More informationparticularly to third-generation cephalosporins,
Research article Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, to 5: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation
More informationIncreasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2008, p. 1190 1194 Vol. 52, No. 3 0066-4804/08/$08.00 0 doi:10.1128/aac.01260-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Increasing
More informationÖrebro University Hospital
Örebro University Hospital Department of Laboratory Medicine Susanne Jacobsson Date: 2015-02-18 Page 1 (8) Neisseria meningitidis 2014 Annual report concerning serogroup, genosubtype and antibiotic susceptibility
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More informationNeisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M.
UvA-DARE (Digital Academic Repository) Neisseria gonorrhoeae: testing, typing and treatment in an era of increased antimicrobial resistance Wind, C.M. Link to publication Citation for published version
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011
Sexually Transmitted Infection surveillance in Northern Ireland 2012 An analysis of data for the calendar year 2011 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationTREATMENT OF JAPANESE PATIENTS WITH ENTERIC FEVER USING AZITHROMYCIN AND MIC LEVELS FOR CAUSATIVE ORGANISMS
TREATMENT OF JAPANESE PATIENTS WITH ENTERIC FEVER USING AZITHROMYCIN AND MIC LEVELS FOR CAUSATIVE ORGANISMS Kenji Ohnishi, Ken-ichiro Kobayashi, Sentaro Iwabuchi and Fukumi Nakamura-Uchiyama Department
More informationCampylobacter Infection. INFECTIOUS DISEASES 2017 A Year in Review 1/30/2018
INFECTIOUS DISEASES 2017 A Year in Review Campylobacter Infection Multistate Outbreak of Multidrug Resistant Campylobacter Infections Linked to Contact with Pet Store Puppies Started September 2017 Has
More informationGlobal challenge of antibiotic-resistant Mycoplasma genitalium. by author. Sabine Pereyre
Global challenge of antibiotic-resistant Mycoplasma genitalium Sabine Pereyre USC EA 3671 Mycoplasmal and chlamydial infections in humans INRA - University of Bordeaux -Bordeaux University Hospital National
More informationFactors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in Neisseria gonorrhoeae, United States
RESEARCH Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in Neisseria gonorrhoeae, United States Edward Goldstein, Robert D. Kirkcaldy, David Reshef,
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationPrevalence of and Associated Risk Factors for Fluoroquinolone-Resistant Neisseria gonorrhoeae in California,
MAJOR ARTICLE Prevalence of and Associated Risk Factors for Fluoroquinolone-Resistant Neisseria gonorrhoeae in California, 2000 2003 Heidi M. Bauer, 1 Karen E. Mark, 4,8,a Michael Samuel, 1 Susan A. Wang,
More informationAzithromycin in the treatment of infection with Neisseria gonorrhoeae
Department of GU Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK Correspondence to Dr Chris Bignell, Department of GU Medicine, Nottingham University Hospitals NHS Trust, City Hospital
More informationWe determined the nucleotide sequence between 1,903 and 3,097 bp of pbp1a
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1998, p. 2267 2273 Vol. 42, No. 9 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Association of a Thr-371 Substitution
More informationExtragenital Infection with Sexually Transmitted Pathogens
Infectious Diseases Extragenital Infection with Sexually Transmitted Pathogens JMAJ 46(9): 41 49, 23 Hiroyuki KOJIMA Former Chief of Urology, Japanese Red Cross Medical Center Abstract: The significant
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationThe CLSI Approach to Setting Breakpoints
The CLSI Approach to Setting Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic
More information